FDA panel votes against new Avastin use

AP/Yahoo News, December 7, 2007
Advisors for the Food and Drug Administration say that Genentech's Avastin cancer drug should not be approved for expanded use in breast-cancer patients.

MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.